The current role of vigabatrin (Sabril®) in the treatment of epilepsies: Results of a consensus conference;Der derzeitige stellenwert von vigabatrin (Sabril®) in der epilepsiebehandlung - Ergebnisse einer konsenskonferenz

Aktuelle Neurologie

Volumn 27, Issue 10, 2000, Pages 470-474

  Schmidt, D ^a   Brandl, U ^a   Elger, C E ^a   Kramer G ^a   Siemes, H ^a   Stephani, U ^a   Aksu, F ^a   Boenigk, H E ^a   Froscher W ^a   Keimer, R ^a   Kluger, G ^a   Kurlemann, G ^a   Rochel, M ^a   Schmitz, B ^a   Stefan, H ^a   Stodieck, S ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIGABATRIN;

DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; FOLLOW UP; HUMAN; PERIMETRY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT FAILURE; TREATMENT PLANNING; VISUAL FIELD DEFECT; WEST SYNDROME;

EID: 18244418075     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017580     Document Type: Review

References (27)

1. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
2. Double-blind study of γ-vinyl GABA in patients with refractory epilepsy
3. Gamma-vinyl GABA: A double-blind, placebo-controlled trial in partial epilepsy
4. Single-blind, placebo-controlled study of vigabatrin (gamma-vinyl-GABA) in drug-resistant epilepsy
5. The new antiepileptic drugs: A systematic review of their efficacy and tolerability
6. Safety and efficacy of vigabtrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised doubleblind study
7. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy
8. Vigabatrin versus carbamazepine monotherapy in newly diagnosed epilepsy: A randomized response conditonal cross-over study
9. Vigabatrin vs. ACTH as first-line treatment for infantile spasms: A randomized, prospective study
10. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
11. Vigabatrin as a first line drug in West Syndrome: Clinical and electroencephalographic outcome
12. Randomized, placebo-controlled study of vigabatrin in first-line treatment of infantile spasms
13. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis. Literature review
14. Severe persistent visual field constriction associated with vigabatrin
15. Severe persistent visual constriction associated with vigabatrin. Reaction may be close dependent
16. Severe persistent visual constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing
17. Severe persistent visual constriction associated with vigabatrin. Four possible explanations exist
18. Vigabatrin-associated bilateral concentric visual field defects in four patients
19. Constriction of the visual field in epilepsy patients taking vigabatrin and other antiepileptic drugs: A longitudinal study
20. Vigabatrin: Reversibility of severe concentric visual field defects after early detection and drug withdrawal: A case report
21. The development of visual functions in cerebrally blind children during a systematic visual field training
22. Valproic acid hepatic fatalities: Retrospective review